RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Recordati Industria Chimica e Farmaceutica SpA Stock

Recordati Industria Chimica e Farmaceutica SpA Debt 2025

Recordati Industria Chimica e Farmaceutica SpA Debt

2,162 EUR

Ticker

REC.MI

ISIN

IT0003828271

WKN

A0EABR

In 2025, Recordati Industria Chimica e Farmaceutica SpA's total debt was 2,162 EUR, a 36.22% change from the 1,587.09 EUR total debt recorded in the previous year.

Recordati Industria Chimica e Farmaceutica SpA Aktienanalyse

What does Recordati Industria Chimica e Farmaceutica SpA do?

Recordati Industria Chimica e Farmaceutica SpA is an Italian pharmaceutical company based in Milan. The company was founded in 1926 by Giovanni Recordati and now has branches in many countries worldwide. Recordati's business model is based on the development, production, and marketing of drugs for various therapeutic areas. The company focuses particularly on therapy areas such as cardiology, urology, gastroenterology, pneumology, and hematology. Recordati operates in four business areas: Innovative Medicines, OTC Medicines, Generics, and Licensed Products. In the area of innovative medicines, the company specializes in the development of new active substances for the treatment of rare diseases. In the OTC Medicines area, Recordati specializes in the manufacture and marketing of over-the-counter drugs used to treat mild to moderate complaints. The generics area includes the production and marketing of generic products with the aim of influencing price development in the market. In the Licensed Products area, Recordati collaborates with other companies and takes over the marketing of their products in certain regions. Some of Recordati's best-known products include Cariprazine (an antipsychotic), Urolith (a preventive treatment for kidney stones), Zanipress (a treatment for hypertension), and Fokusin (a treatment for benign prostatic hyperplasia). Recordati is also committed to improving access to life-saving medications worldwide. The company engages in collaborations with international organizations such as the Global Alliance for TB Drug Development and supports the WHO's "Target Product Profiles" initiative. In 2019, Recordati Industria Chimica e Farmaceutica SpA achieved sales of around 1.4 billion euros in over 90 countries. The company employs about 4,200 people worldwide, including approximately 500 researchers and developers. In terms of future direction, Recordati sees continued high potential for growth and expansion, particularly through targeted investments in research and development. The company relies on close cooperation with other partners within the industry and the exploration of new markets and therapeutic areas. Recordati Industria Chimica e Farmaceutica SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Recordati Industria Chimica e Farmaceutica SpA's Debt Structure

Recordati Industria Chimica e Farmaceutica SpA's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Recordati Industria Chimica e Farmaceutica SpA's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Recordati Industria Chimica e Farmaceutica SpA’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Recordati Industria Chimica e Farmaceutica SpA’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Recordati Industria Chimica e Farmaceutica SpA stock

What is the debt of Recordati Industria Chimica e Farmaceutica SpA this year?

Recordati Industria Chimica e Farmaceutica SpA has a debt level of 2,162 EUR this year.

What was the debt of Recordati Industria Chimica e Farmaceutica SpA compared to the previous year?

The debt of Recordati Industria Chimica e Farmaceutica SpA has increased by 36.22% compared to the previous year increased.

What are the consequences of high debt for investors in Recordati Industria Chimica e Farmaceutica SpA?

High debt can pose a risk for investors of Recordati Industria Chimica e Farmaceutica SpA, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Recordati Industria Chimica e Farmaceutica SpA?

Low debt means that Recordati Industria Chimica e Farmaceutica SpA has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Recordati Industria Chimica e Farmaceutica SpA affect the company?

An increase in debt of Recordati Industria Chimica e Farmaceutica SpA can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Recordati Industria Chimica e Farmaceutica SpA affect the company?

A reduction in debt of Recordati Industria Chimica e Farmaceutica SpA can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Recordati Industria Chimica e Farmaceutica SpA?

Some factors that can influence the debt of Recordati Industria Chimica e Farmaceutica SpA include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Recordati Industria Chimica e Farmaceutica SpA so important for investors?

The debts of Recordati Industria Chimica e Farmaceutica SpA are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Recordati Industria Chimica e Farmaceutica SpA take to change the debt?

To change the debt, Recordati Industria Chimica e Farmaceutica SpA can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Recordati Industria Chimica e Farmaceutica SpA pay?

Over the past 12 months, Recordati Industria Chimica e Farmaceutica SpA paid a dividend of 1.23 EUR . This corresponds to a dividend yield of about 2.36 %. For the coming 12 months, Recordati Industria Chimica e Farmaceutica SpA is expected to pay a dividend of 2.02 EUR.

What is the dividend yield of Recordati Industria Chimica e Farmaceutica SpA?

The current dividend yield of Recordati Industria Chimica e Farmaceutica SpA is 2.36 %.

When does Recordati Industria Chimica e Farmaceutica SpA pay dividends?

Recordati Industria Chimica e Farmaceutica SpA pays a quarterly dividend. This is distributed in the months of December, June, December, June.

How secure is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

Recordati Industria Chimica e Farmaceutica SpA paid dividends every year for the past 10 years.

What is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

For the upcoming 12 months, dividends amounting to 2.02 EUR are expected. This corresponds to a dividend yield of 3.88 %.

In which sector is Recordati Industria Chimica e Farmaceutica SpA located?

Recordati Industria Chimica e Farmaceutica SpA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Recordati Industria Chimica e Farmaceutica SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Recordati Industria Chimica e Farmaceutica SpA from 5/21/2025 amounting to 0.67 EUR, you needed to have the stock in your portfolio before the ex-date on 5/19/2025.

When did Recordati Industria Chimica e Farmaceutica SpA pay the last dividend?

The last dividend was paid out on 5/21/2025.

What was the dividend of Recordati Industria Chimica e Farmaceutica SpA in the year 2024?

In the year 2024, Recordati Industria Chimica e Farmaceutica SpA distributed 1.17 EUR as dividends.

In which currency does Recordati Industria Chimica e Farmaceutica SpA pay out the dividend?

The dividends of Recordati Industria Chimica e Farmaceutica SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Recordati Industria Chimica e Farmaceutica SpA

Our stock analysis for Recordati Industria Chimica e Farmaceutica SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recordati Industria Chimica e Farmaceutica SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.